more_reports

The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports

Biotech Announces Topline Results From Cardiovascular Drug Trial

Research Report
  ()
Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) Analyst Brandon Folkes reviews Cardiol Therapeutics Inc. after it announced the topline results from its Phase II ARCHER trial of CardiolRx in acute myocarditis.
Tags: Biotechnology / Pharmaceuticals

Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada

Research Report
  ()
Top-line results from Cardiol Therapeutics' (CRDL:TSX; CRDL:NASDAQ) ARCHER study for Acute Myocarditis are quite promising, writes Roth Capital Partners Analyst Jason Wittes in an updated research note.
Tags: Biotechnology / Pharmaceuticals

Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment

  ()
Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) announces topline results from its Phase II clinical study involving patients with acute myocarditis. Read why analysts like this pharmaceutical stock.
Tags: Biotechnology / Pharmaceuticals

Canadian Pharma Finds Promising Cardiovascular Breakthrough

Research Report
  ()
Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) reports headline Phase II data from its 109-patient acute myocarditis study, known as the ARCHER trial. Read to see how one analyst rates the stock.
Tags: Biotechnology / Pharmaceuticals

Clean Tech Firm Making Important PFAS Breakthrough

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) president and chief executive office shares a mid-year update on the company's achievements so far this year, along with insights into its future prospects through a letter to shareholders.
Tags: Alternative - CleantechTechnologyBattery MetalsBiotechnology / PharmaceuticalsSpecial Situations

Cancer Drug Developer Finds Potent Hits With AI in British Columbia

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) taps machine learning to zero in on novel cancer therapies. Read more about the AI engine driving this high-stakes discovery.
Tags: Biotechnology / Pharmaceuticals

Pancreas Cancer Becoming Top Focus for Biotech Co.?

Research Report
  ()
Oncolytics Biotech Inc. (ONCY:NASDAQ; ONC:TSX) published survival data for the use of its immunotherapy pelareorep in pancreatic cancer, and these support the view that this indication should be primary, noted a Leede Financial Inc. report.
Tags: Biotechnology / Pharmaceuticals

Biotech Firm Clears Major U.S. Trading Hurdle

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) just gained DTC eligibility, opening the door for faster U.S. trades and broader investor access. With AI-driven cancer drugs in development, analysts are taking notice. Read more to find out why.
Tags: Biotechnology / Pharmaceuticals

Biotech Partnership to Revolutionize Diabetes Treatment

  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) announces a collaborative research agreement with Eledon Pharmaceuticals Inc. to assess Eledon's immunosuppressive drug in Sernova's ongoing trials of its cell pouch biohybrid organ for patients with Type 1 diabetes (T1D).
Tags: Biotechnology / Pharmaceuticals

AI Healthtech Firm Partners with EngageWell and CVS Health Foundation on NYC Senior Care Initiative

  ()
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launches virtual screening for older adults in NYC, backed by US$1M from CVS Health Foundation, as it scales AI tools and patient reach. Read more about how this initiative is helping expand access to care and driving growth in virtual health innovation.
Tags: Biotechnology / Pharmaceuticals

Biopharma Firm Assembles Elite AI Cancer Team

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) strengthens its AI-driven cancer program with a world-class advisory board and breakthrough drug discovery platforms. Read more about how Rakovina's expert-backed strategy and proprietary platforms support next-gen oncology drug development and potential licensing deals.
Tags: Biotechnology / Pharmaceuticals

Canadian Biotech Targets Massive Cell Technology Gains

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) recently announced a partnership with Eledon Pharmaceuticals Inc. (ELDN:NASDAQ) to explore the utility of Eledon's clinical-stage anti-CD40L monoclonal antibody tegoprubart/AT-1501 for conferring sustainable immune evasion of pancreatic islets deployed into Sernova's Cell Pouch device. Read on to see why one Leede Financial Inc. analyst rates this stock as a Speculative Buy.
Tags: Biotechnology / Pharmaceuticals

Biotech Co. Still a Buy Despite Manufacturing Setbacks

Research Report
  ()
While it received a lower price target due to manufacturing setbacks, Jasper Therapeutics Inc. (JSPR:NASDAQ) is still a Buy, according to an H.C. Wainwright & Co. research note.
Tags: Biotechnology / Pharmaceuticals

Vaccine Co. Secures European Regulatory Breakthrough Potential

Research Report
  ()
GeoVax Labs Inc. (GOVX:NASDAQ) recently raised US$6 million, projected to find operations through the last quarter of 2025, according to a ROTH Capital Markets research note. The company also received highly favorable guidance for GEO-MVA, its prophylactic vaccine for Mpox and smallpox from The European Medicines Agency.
Tags: Biotechnology / Pharmaceuticals

Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion

  ()
Canadian healthcare and clinical stage drug development company Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) updates the pricing and warrant terms for its previously announced non-brokered private placement. Read why one technical analyst thinks the stock is ready to break out.
Tags: Life Sciences Tools & DiagnosticsBiotechnology / PharmaceuticalsPsychedelics

Biotech Company Finds DNA-Targeting Drugs with AI in Canada

  ()
Biopharmaceutical company Rakovina Therapeutics Inc. (RKV:TSX.V) shared AGM results and key AI-driven cancer drug milestones in Vancouver. Read why some analysts are seeing a 300% potential return
Tags: Biotechnology / Pharmaceuticals

Analyst Has Confidence in Biotech's Path

Research Report
  ()
Vertex Pharmaceuticals Inc.'s (VRTX:NASDAQ) updated data is "a strong positive read-through for Sernova and help de-risk the broader field of cell-based therapies in T1D," according to an H.C. Wainwright & Co. research note.
Tags: Biotechnology / Pharmaceuticals

Isotope Co. Discovers Uranium-Helium Breakthrough Potential

  ()
ASP Isotopes Inc. (ASPI:NASDAQ) is seeing at least two major transformative developments this month. Read why one analyst sees these events as positive.
Tags: UraniumTechnologySpecial SituationsBiotechnology / Pharmaceuticals

Sirens of High Finance

Contributed Opinion
  ()
Michael Ballanger of GGM Advisory Inc. shares his take on the current state of the market and reviews one copper stock he has been betting on for a while.
Tags: TechnologyCritical MetalsBiotechnology / PharmaceuticalsGold

California Biotech's Trial Shows Encouraging Results

Research Report
  ()
Kura Oncology Inc.'s (KURA:NASDAQ) KOMET-007 trial results, supporting ziftomenib's benefit-risk profile for first-line acute myeloid leukemia, were encouraging, according to an H.C. Wainwright & Co. research note.
Tags: Biotechnology / Pharmaceuticals

Orogen: End of Another Chapter Draws Near

Contributed Opinion
  ()
Global Analyst Adrian Day discusses developments at some companies on his list, including Orogen Royalties Inc. (OGN:TSXV; OGNRF:OTCQX) and Franco-Nevada Corp. (FNV:TSX; FNV:NYSE).
Tags: SilverGoldBiotechnology / Pharmaceuticals

Q1/25 Financials of Cancer Drug Developer Released

Research Report
  ()
Rakovina Therapeutics Inc.'s (RKV:TSX.V) CA$4 million equity offering is nearing completion, noted a Leede Financial Inc. report.
Tags: Biotechnology / Pharmaceuticals

Biotech Firm Unveils Diabetes Breakthrough in Canada

  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) advanced its Cell Pouch device in Canada with insulin-free outcomes in all trial patients and a CA$6 target price from analysts. Read more to find out how expert advisors, international funding, and a next-gen clinical pipeline could reshape treatment for type 1 diabetes.
Tags: Biotechnology / Pharmaceuticals

New RA Drug Shown to Work, Be Safe

Research Report
  ()
"Efficacy at six months represented a 'best case' scenario, in our view," and "safety was very favorable," noted a Wedbush report.
Tags: Biotechnology / Pharmaceuticals

Analyst Likes Co. Developing Immuno-oncology Drugs

Research Report
  ()
There are multiple reasons to be bullish on this undervalued stock with significant potential upside, noted an H.C. Wainwright & Co. report.
Tags: Biotechnology / Pharmaceuticals

Showing Results: 1 to 25 of 71 Next